Anebulo Pharmaceuticals, Inc. — All Filings
198 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
15-12G
25
3
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-8
S-8 POS
SC 13D
SC 13E3
SC 13E3/A
SC TO-I
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | — | 0001493152-23-034696 | Sep 29, 2023 | Sep 26, 2023 |
| 10-K | — | 0001493152-23-033452 | Sep 22, 2023 | Jun 30, 2023 |
| 8-K | — | 0001493152-23-033196 | Sep 20, 2023 | — |
| 8-K | — | 0001493152-23-031568 | Sep 5, 2023 | Aug 29, 2023 |
| 10-Q | — | 0001493152-23-016382 | May 11, 2023 | Mar 31, 2023 |
| 8-K | — | 0001493152-23-016291 | May 11, 2023 | — |
| 8-K | — | 0001493152-23-011805 | Apr 11, 2023 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-23-022954 | Apr 4, 2023 | Mar 2, 2023 |
| 8-K | 8-K | 0001193125-23-081417 | Mar 28, 2023 | — |
| 8-K | — | 0001493152-23-006974 | Mar 8, 2023 | Mar 2, 2023 |
| 10-Q | — | 0001493152-23-004203 | Feb 10, 2023 | Dec 31, 2022 |
| 8-K | — | 0001493152-23-004202 | Feb 10, 2023 | — |
| 8-K | — | 0001493152-23-000900 | Jan 9, 2023 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-061093 | Dec 13, 2022 | Dec 9, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-061091 | Dec 13, 2022 | Dec 9, 2022 |
| EFFECT | — | 9999999995-22-003277 | Nov 10, 2022 | — |
| 10-Q | — | 0001493152-22-031239 | Nov 10, 2022 | Sep 30, 2022 |
| 8-K | — | 0001493152-22-031235 | Nov 10, 2022 | — |
| CORRESP | — | 0001493152-22-030952 | Nov 8, 2022 | — |
| UPLOAD | — | 0000000000-22-012164 | Nov 8, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-055300 | Nov 2, 2022 | Nov 1, 2022 |
| 3 | FORM 3 SUBMISSION | 0001209191-22-055289 | Nov 2, 2022 | Oct 28, 2022 |
| S-1 | — | 0001493152-22-030199 | Nov 2, 2022 | — |
| 8-K | — | 0001493152-22-029837 | Oct 28, 2022 | — |
| DEFR14A | — | 0001493152-22-029551 | Oct 25, 2022 | — |
| DEF 14A | — | 0001493152-22-028523 | Oct 17, 2022 | — |
| 8-K | — | 0001493152-22-028331 | Oct 13, 2022 | Oct 11, 2022 |
| D | — | 0001169987-22-000002 | Oct 11, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-052202 | Oct 4, 2022 | Apr 21, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-052187 | Oct 4, 2022 | Apr 21, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-051983 | Oct 3, 2022 | Apr 21, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-051982 | Oct 3, 2022 | Apr 21, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-051981 | Oct 3, 2022 | Apr 21, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-051980 | Oct 3, 2022 | Jun 27, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-051688 | Sep 30, 2022 | Apr 21, 2022 |
| 8-K | — | 0001493152-22-027158 | Sep 29, 2022 | Sep 25, 2022 |
| 8-K | — | 0001493152-22-026752 | Sep 26, 2022 | — |
| 10-K | — | 0001493152-22-025448 | Sep 9, 2022 | Jun 30, 2022 |
| 8-K | — | 0001493152-22-025445 | Sep 9, 2022 | — |
| 8-K | — | 0001493152-22-018455 | Jul 5, 2022 | — |
| 4 | — | 0001493152-22-016081 | Jun 7, 2022 | Jun 1, 2022 |
| 3 | — | 0001493152-22-014954 | May 24, 2022 | May 20, 2022 |
| 8-K | — | 0001493152-22-014942 | May 24, 2022 | — |
| 10-Q | — | 0001493152-22-012848 | May 11, 2022 | Mar 31, 2022 |
| 8-K | — | 0001493152-22-012786 | May 11, 2022 | — |
| S-8 | — | 0001493152-22-010667 | Apr 22, 2022 | — |
| 8-K | — | 0001493152-22-008679 | Apr 1, 2022 | — |
| 10-Q | — | 0001493152-22-003883 | Feb 11, 2022 | Dec 31, 2021 |
| 8-K | — | 0001493152-22-003881 | Feb 11, 2022 | — |
| 4 | — | 0001493152-22-003365 | Feb 7, 2022 | — |